Free Trial

Lexaria Bioscience (LXX) News Today

→ Bigger Than NVIDIA? (From Behind the Markets) (Ad)
Free LXX Stock Alerts
Compare
Headlines
Stock Analysis
April 9, 2024 | msn.com
LEXX Stock Earnings: Lexaria Bioscience Beats EPS for Q2 2024
February 22, 2024 | benzinga.com
Lexaria Bioscience Stock (NASDAQ:LEXXW) Dividends: History, Yield and Dates
January 30, 2024 | msn.com
Lexaria submits IND to begin Phase 1b study of DehyraTECH-CBD
December 1, 2023 | markets.businessinsider.com
Buy Rating on Lexaria Bioscience: Promising DehydraTECH Study and Market Potential
November 27, 2023 | msn.com
Lexaria stock rallies 20% on positive GLP-1 drug delivery study
July 22, 2023 | msn.com
Maxim Group Initiates Coverage of Lexaria Bioscience (LEXX) with Buy Recommendation
June 16, 2023 | benzinga.com
Lexaria's DehydraTECH-CBD Lowers Blood Glucose Levels in Diabetes Animal Study
May 12, 2023 | marketwatch.com
CannabisNewsBreaks - Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Results of 2023 Annual Meeting
May 9, 2023 | benzinga.com
Lexaria Bioscience shares are trading lower after the company priced a 2.1 million unit offering at $0.95 per unit.
May 9, 2023 | msn.com
Lexaria Bioscience prices $2.0M stock offering
May 8, 2023 | benzinga.com
Lexaria's Human Clinical Nicotine Study Completes Dosing as Planned
April 26, 2023 | finance.yahoo.com
LEXX: DehydraTECH CBD May Offer New Mechanism of Action
March 4, 2023 | finanznachrichten.de
Lexaria Bioscience Corp.: Lexaria's DehydraTECH-CBD Diabetes Study Demonstrates Weight Loss, Improved Triglyceride and Cholesterol Levels
February 22, 2023 | nasdaq.com
Lexaria Bioscience Corp. Common Stock (LEXX)
September 26, 2022 | finance.yahoo.com
Lexaria Bioscience Corp. (LEXX)
August 31, 2022 | finance.yahoo.com
Lexaria Receives New Patent in Mexico
August 12, 2022 | marketwatch.com
NetworkNewsAudio - Lexaria Bioscience Corp. (NASDAQ: LEXX) Pioneering Innovative Hypertension Treatments
August 12, 2022 | marketwatch.com
CannabisNewsBreaks - Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Positive FDA Feedback Concerning Opening IND Program
August 11, 2022 | apnews.com
Lexaria Bioscience Corp. (NASDAQ: LEXX) Focused on Filling Need for Hypertension Treatment Solution
August 11, 2022 | finance.yahoo.com
Lexaria Discusses Valuation Metrics for Biotech Industry
August 10, 2022 | finance.yahoo.com
Lexaria Announces Positive Feedback from Pre-IND Meeting with FDA on DehydraTECH-CBD for Hypertension
July 27, 2022 | msn.com
Lexaria's DehydraTECH CBD Hypertension Study Dosing Complete With No Serious Adverse Events
June 21, 2022 | finance.yahoo.com
Lexaria Signs Manufacturing and License Agreements with BevNology
June 21, 2022 | seekingalpha.com
Lexaria stock soars 19% on 2 manufacturing/license agreements with BevNology
June 3, 2022 | seekingalpha.com
Lexaria inks licensing deal for drug delivery tech with Premier Wellness for Japanese market
May 26, 2022 | finance.yahoo.com
Lexaria Bioscience Corp. (NASDAQ: LEXX) Stands as Global Leader in Delivery Tech Space
January 4, 2022 | stockhouse.com
Lexaria Bioscience Corp. LEXXW
December 8, 2021 | benzinga.com
Read Why Lexaria Bioscience Shares Are Surging During Wednesday Premarket?
October 2, 2021 | proactiveinvestors.com
Bhang announces expanded partnership with US-based Trulieve Cannabis
September 16, 2021 | proactiveinvestors.com
Bhang brings on Wes Eder as global vice president of revenue
September 7, 2021 | benzinga.com
Lexaria Bioscience's Formulated Cannabidiol Lowers Blood Pressure In Hypertension Patients
Get Lexaria Bioscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for LXX and its competitors with MarketBeat's FREE daily newsletter.

Will this AI Micro-Cap be Bigger than NVIDIA? (Ad)

With NVIDIA flying high, everyone is looking for the next breakout AI stock. But right now... There's only ONE AI stock you should be watching.

Get the full story here >>>

LXX Media Mentions By Week

LXX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LXX
News Sentiment
▼
0.00

0.36
▲
Average
Consumer Defensive
News Sentiment

LXX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LXX Articles
This Week
▼
0

0
▲
LXX Articles
Average Week

Get Lexaria Bioscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for LXX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (CNSX:LXX) was last updated on 6/18/2024 by MarketBeat.com Staff

From Our Partners
Bigger Than NVIDIA?
With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...
Behind the Markets | Sponsored
Beta testers blew this thing up
This AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...
Prosper Trading Academy | Sponsored
Radical change coming — do this NOW to protect yourself
I recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...
Weiss Ratings | Sponsored
AI's Next Magnificent Seven
The Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.
The Oxford Club | Sponsored
The #1 Crypto That You Don’t Own… Yet
There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...
Crypto 101 Media | Sponsored
Breaking News: Elon Musk Invents New Type of A.I. (Shocking)
Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...
InvestorPlace | Sponsored
Inflation Is Robbing You Blind! Here’s How to Fight Back!
Quietly, inflation has reduced your purchasing power by 29.4% since 2014. So something that cost $100 in 20...
American Alternative | Sponsored
Missed NVDA? Buy this AI stock NOW
After Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in sev...
Chaikin Analytics | Sponsored